Annual Shareholders Equity
$89.01 B
-$6.65 B-6.95%
31 December 2023
Summary:
Pfizer annual stockholders equity is currently $89.01 billion, with the most recent change of -$6.65 billion (-6.95%) on 31 December 2023. During the last 3 years, it has risen by +$25.78 billion (+40.76%). PFE annual shareholders equity is now -6.95% below its all-time high of $95.66 billion, reached on 31 December 2022.PFE Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Shareholders Equity
$92.29 B
+$4.59 B+5.23%
30 September 2024
Summary:
Pfizer quarterly stockholders equity is currently $92.29 billion, with the most recent change of +$4.59 billion (+5.23%) on 30 September 2024. Over the past year, it has dropped by -$4.65 billion (-4.80%). PFE quarterly shareholders equity is now -8.60% below its all-time high of $100.97 billion, reached on 31 March 2023.PFE Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PFE Shareholders Equity Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -7.0% | -4.8% |
| 3 y3 years | +40.8% | +21.9% |
| 5 y5 years | +40.4% | +41.8% |
PFE Shareholders Equity High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -7.0% | +40.8% | -8.6% | +21.9% |
| 5 y | 5 years | -7.0% | +41.0% | -8.6% | +46.1% |
| alltime | all time | -7.0% | +3482.8% | -8.6% | +3614.5% |
Pfizer Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $92.29 B(+5.2%) |
| June 2024 | - | $87.70 B(-5.0%) |
| Mar 2024 | - | $92.28 B(+3.7%) |
| Dec 2023 | $89.01 B(-6.9%) | $89.01 B(-8.2%) |
| Sept 2023 | - | $96.93 B(-2.1%) |
| June 2023 | - | $99.02 B(-1.9%) |
| Mar 2023 | - | $100.97 B(+5.5%) |
| Dec 2022 | $95.66 B(+23.9%) | $95.66 B(+3.3%) |
| Sept 2022 | - | $92.63 B(+6.2%) |
| June 2022 | - | $87.21 B(+5.8%) |
| Mar 2022 | - | $82.42 B(+6.8%) |
| Dec 2021 | $77.20 B(+22.1%) | $77.20 B(+2.0%) |
| Sept 2021 | - | $75.69 B(+8.1%) |
| June 2021 | - | $70.04 B(+2.1%) |
| Mar 2021 | - | $68.62 B(+8.5%) |
| Dec 2020 | $63.24 B(+0.2%) | $63.24 B(-3.1%) |
| Sept 2020 | - | $65.26 B(+1.4%) |
| June 2020 | - | $64.34 B(-1.1%) |
| Mar 2020 | - | $65.03 B(+3.0%) |
| Dec 2019 | $63.14 B(-0.4%) | $63.14 B(-3.0%) |
| Sept 2019 | - | $65.10 B(+9.3%) |
| June 2019 | - | $59.57 B(+1.3%) |
| Mar 2019 | - | $58.81 B(-7.3%) |
| Dec 2018 | $63.41 B(-11.1%) | $63.41 B(-11.1%) |
| Sept 2018 | - | $71.32 B(+2.2%) |
| June 2018 | - | $69.78 B(-0.6%) |
| Mar 2018 | - | $70.18 B(-1.6%) |
| Dec 2017 | $71.31 B(+19.8%) | $71.31 B(+17.3%) |
| Sept 2017 | - | $60.77 B(+4.1%) |
| June 2017 | - | $58.37 B(-0.1%) |
| Mar 2017 | - | $58.44 B(-1.9%) |
| Dec 2016 | $59.54 B(-8.0%) | $59.54 B(-5.9%) |
| Sept 2016 | - | $63.31 B(+0.9%) |
| June 2016 | - | $62.77 B(-0.5%) |
| Mar 2016 | - | $63.07 B(-2.6%) |
| Dec 2015 | $64.72 B(-9.2%) | $64.72 B(-3.2%) |
| Sept 2015 | - | $66.84 B(-0.1%) |
| June 2015 | - | $66.89 B(-0.6%) |
| Mar 2015 | - | $67.30 B(-5.6%) |
| Dec 2014 | $71.30 B(-6.6%) | $71.30 B(-8.6%) |
| Sept 2014 | - | $77.99 B(+1.8%) |
| June 2014 | - | $76.63 B(-1.5%) |
| Mar 2014 | - | $77.77 B(+1.9%) |
| Dec 2013 | $76.31 B(-6.1%) | $76.31 B(-2.1%) |
| Sept 2013 | - | $77.97 B(-0.7%) |
| June 2013 | - | $78.55 B(-4.5%) |
| Mar 2013 | - | $82.25 B(+1.2%) |
| Dec 2012 | $81.26 B(-1.1%) | $81.26 B(-0.5%) |
| Sept 2012 | - | $81.70 B(+2.7%) |
| June 2012 | - | $79.55 B(-4.5%) |
| Mar 2012 | - | $83.26 B(+1.3%) |
| Dec 2011 | $82.19 B(-6.4%) | $82.19 B(-8.7%) |
| Sept 2011 | - | $90.05 B(+1.8%) |
| June 2011 | - | $88.48 B(-1.8%) |
| Mar 2011 | - | $90.07 B(+2.6%) |
| Dec 2010 | $87.81 B(-2.4%) | $87.81 B(+0.2%) |
| Sept 2010 | - | $87.64 B(+1.4%) |
| June 2010 | - | $86.44 B(-3.6%) |
| Mar 2010 | - | $89.66 B(-0.4%) |
| Dec 2009 | $90.01 B(+56.4%) | $90.01 B(+36.1%) |
| Sept 2009 | - | $66.16 B(+4.9%) |
| June 2009 | - | $63.04 B(+4.6%) |
| Mar 2009 | - | $60.26 B(+4.7%) |
| Dec 2008 | $57.56 B(-11.5%) | $57.56 B(-14.5%) |
| Sept 2008 | - | $67.33 B(+1.2%) |
| June 2008 | - | $66.57 B(-1.3%) |
| Mar 2008 | - | $67.42 B(+3.7%) |
| Dec 2007 | $65.01 B(-8.9%) | $65.01 B(-2.4%) |
| Sept 2007 | - | $66.61 B(-2.2%) |
| June 2007 | - | $68.09 B(-6.1%) |
| Mar 2007 | - | $72.49 B(+1.6%) |
| Dec 2006 | $71.36 B | $71.36 B(+2.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2006 | - | $69.71 B(+1.8%) |
| June 2006 | - | $68.49 B(-1.6%) |
| Mar 2006 | - | $69.61 B(+5.8%) |
| Dec 2005 | $65.76 B(-3.7%) | $65.76 B(-1.6%) |
| Sept 2005 | - | $66.81 B(+2.3%) |
| June 2005 | - | $65.33 B(-3.3%) |
| Mar 2005 | - | $67.53 B(-1.1%) |
| Dec 2004 | $68.28 B(+4.4%) | $68.28 B(-0.2%) |
| Sept 2004 | - | $68.38 B(+2.5%) |
| June 2004 | - | $66.70 B(-3.4%) |
| Mar 2004 | - | $69.05 B(+5.6%) |
| Dec 2003 | $65.38 B(+227.7%) | $65.38 B(-4.6%) |
| Sept 2003 | - | $68.53 B(-2.5%) |
| June 2003 | - | $70.28 B(+182.9%) |
| Mar 2003 | - | $24.84 B(+24.5%) |
| Dec 2002 | $19.95 B(+9.1%) | $19.95 B(+5.3%) |
| Sept 2002 | - | $18.95 B(+0.7%) |
| June 2002 | - | $18.83 B(-4.3%) |
| Mar 2002 | - | $19.67 B(+7.5%) |
| Dec 2001 | $18.29 B(+13.8%) | $18.29 B(-3.2%) |
| Sept 2001 | - | $18.90 B(+6.1%) |
| June 2001 | - | $17.82 B(+0.4%) |
| Mar 2001 | - | $17.75 B(+10.4%) |
| Dec 2000 | $16.08 B(+15.2%) | $16.08 B(-0.6%) |
| Sept 2000 | - | $16.17 B(+8.0%) |
| June 2000 | - | $14.97 B(+47.0%) |
| Mar 2000 | - | $10.19 B(-27.0%) |
| Dec 1999 | $13.95 B(+58.3%) | $13.95 B(+58.8%) |
| Sept 1999 | - | $8.79 B(+1.6%) |
| June 1999 | - | $8.65 B(-4.4%) |
| Mar 1999 | - | $9.04 B(+2.7%) |
| Dec 1998 | $8.81 B(+11.1%) | $8.81 B(+1.9%) |
| Sept 1998 | - | $8.64 B(+4.1%) |
| June 1998 | - | $8.30 B(+1.4%) |
| Mar 1998 | - | $8.19 B(+3.2%) |
| Dec 1997 | $7.93 B(+14.1%) | $7.93 B(+7.1%) |
| Sept 1997 | - | $7.41 B(+3.2%) |
| June 1997 | - | $7.17 B(+0.3%) |
| Mar 1997 | - | $7.15 B(+2.8%) |
| Dec 1996 | $6.95 B(+26.3%) | $6.95 B(+5.9%) |
| Sept 1996 | - | $6.57 B(+9.7%) |
| June 1996 | - | $5.98 B(+1.6%) |
| Mar 1996 | - | $5.89 B(+6.9%) |
| Dec 1995 | $5.51 B(+27.4%) | $5.51 B(+4.3%) |
| Sept 1995 | - | $5.28 B(+9.4%) |
| June 1995 | - | $4.83 B(+2.8%) |
| Mar 1995 | - | $4.70 B(+8.6%) |
| Dec 1994 | $4.32 B(+11.9%) | $4.32 B(+4.1%) |
| Sept 1994 | - | $4.15 B(+10.8%) |
| June 1994 | - | $3.75 B(-2.4%) |
| Mar 1994 | - | $3.84 B(-0.7%) |
| Dec 1993 | $3.87 B(-18.1%) | $3.87 B(+1.1%) |
| Sept 1993 | - | $3.82 B(-9.2%) |
| June 1993 | - | $4.21 B(-5.5%) |
| Mar 1993 | - | $4.45 B(-5.6%) |
| Dec 1992 | $4.72 B(-6.1%) | $4.72 B(-13.7%) |
| Sept 1992 | - | $5.47 B(+8.7%) |
| June 1992 | - | $5.03 B(-0.6%) |
| Mar 1992 | - | $5.06 B(+0.7%) |
| Dec 1991 | $5.03 B(-1.3%) | $5.03 B(-0.9%) |
| Sept 1991 | - | $5.07 B(+5.0%) |
| June 1991 | - | $4.83 B(-6.8%) |
| Mar 1991 | - | $5.18 B(+1.7%) |
| Dec 1990 | $5.09 B(+12.3%) | $5.09 B(+1.6%) |
| Sept 1990 | - | $5.01 B(+7.1%) |
| June 1990 | - | $4.68 B(-1.3%) |
| Mar 1990 | - | $4.74 B(+4.5%) |
| Dec 1989 | $4.54 B(+5.5%) | $4.54 B(+5.5%) |
| Dec 1988 | $4.30 B(+10.8%) | $4.30 B(+10.8%) |
| Dec 1987 | $3.88 B(+13.7%) | $3.88 B(+13.7%) |
| Dec 1986 | $3.42 B(+16.7%) | $3.42 B(+16.7%) |
| Dec 1985 | $2.93 B(+17.8%) | $2.93 B(+17.8%) |
| Dec 1984 | $2.48 B | $2.48 B |
FAQ
- What is Pfizer annual stockholders equity?
- What is the all time high annual shareholders equity for Pfizer?
- What is Pfizer annual shareholders equity year-on-year change?
- What is Pfizer quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Pfizer?
- What is Pfizer quarterly shareholders equity year-on-year change?
What is Pfizer annual stockholders equity?
The current annual shareholders equity of PFE is $89.01 B
What is the all time high annual shareholders equity for Pfizer?
Pfizer all-time high annual stockholders equity is $95.66 B
What is Pfizer annual shareholders equity year-on-year change?
Over the past year, PFE annual stockholders equity has changed by -$6.65 B (-6.95%)
What is Pfizer quarterly stockholders equity?
The current quarterly shareholders equity of PFE is $92.29 B
What is the all time high quarterly shareholders equity for Pfizer?
Pfizer all-time high quarterly stockholders equity is $100.97 B
What is Pfizer quarterly shareholders equity year-on-year change?
Over the past year, PFE quarterly stockholders equity has changed by -$4.65 B (-4.80%)